 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||||||
A handheld, short-term magnetic stimulation device relieved migraine-aura pain for as long as 48 hours after a single treatment session, according to results of a randomized clinical trial.
Almost twice as ...
A handheld, short-term magnetic stimulation device relieved migraine-aura pain for as long as 48 hours after a single treatment session, according to results of a randomized clinical trial.
Almost twice as ...
SAN FRANCISCO — A potent capsaicin patch (Qutenza), recently approved to ease neuropathic pain from shingles, burned hopes for similar efficacy in HIV-associated distal sensory polyneuropathy.
The patch reduced ...
Women with physician-diagnosed migraine appear to have an increased risk of developing multiple sclerosis (MS), researchers found.
Among female nurses, the rate of migraine was higher among those who were eventually ...
Women with physician-diagnosed migraine appear to have an increased risk of developing multiple sclerosis (MS), researchers found.
Among female nurses, the rate of migraine was higher among those who were eventually ...
Chronic migraine sufferers tended to be poorer and less healthy than those who get migraines only occasionally, researchers found.
Compared with episodic sufferers, chronic migraineurs had lower household income (P=0.02). Nearly ...
SAN FRANCISCO — A potent capsaicin patch (Qutenza), recently approved to ease neuropathic pain from shingles, burned hopes for similar efficacy in HIV-associated distal sensory polyneuropathy.
The patch reduced ...
TORONTO — Regular use of ibuprofen (Advil, Motrin) again appeared to have a neuroprotective effect against Parkinson’s disease in observational study results.
Use at least twice a week was ...
Botulinum toxin type A (Botox) provided significant relief from certain types of migraine in a small clinical study of migraine patients undergoing cosmetic procedures of the upper face.
Mean migraine frequency ...
Nonsteroidal anti-inflammatory drugs (NSAIDs) offer no protection against skin cancer, investigators concluded from a review of records for a massive patient cohort.
The review yielded inconsistent and nonsignificant associations between squamous-cell ...
SAN ANTONIO — A personalized, on-line self-management program helped patients with pain syndromes improve coping skills and reduce stress and depression in two studies reported here.
Patients randomized to ...
SAN ANTONIO — Spinal cord stimulation provided durable pain relief for patients with complex regional pain syndrome (CRPS) but did not halt progression, a retrospective analysis of a ...
SAN ANTONIO — Subcutaneous injection of botulinum toxin A (Botox) significantly reduced postherpetic neuralgia compared with lidocaine and saline placebo in a small randomized clinical study, researchers reported ...
SAN ANTONIO — The fibromyalgia drug milnacipran (Savella) achieved clinically meaningful reductions in pain throughout almost four months of randomized therapy, a post-hoc analysis of daily pain control ...
SAN ANTONIO — Patients with fibromyalgia and comorbid depression had significant improvement in both conditions when treated with duloxetine (Cymbalta), according to pooled data from four clinical trials ...
SAN ANTONIO — Patients with neuropathic cancer pain obtained consistent, long-term pain control with extended-release oxymorphone (Opana), according to results of a one-year, open-label extension study.
Patients reported pain ...
SAN ANTONIO — Patients with neuropathic cancer pain obtained consistent, long-term pain control with extended-release oxymorphone (Opana), according to results of a one-year, open-label extension study.
Patients reported pain ...